Pathogenetic aspects of the influence of gliflozins on erythropoiesis and iron metabolism in patients with chronic heart failure
Background. Sodium glucose cotransporter type 2 (SGLT2) inhibitors, established over the past decade, including dapagliflozin, empagliflozin, and canagliflozin, have demonstrated significant reductions in hospitalization and mortality in patients with diabetes mellitus and chronic heart failure in a...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2024-04-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/1198 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|